New York Attorney General Eliot Spitzer appears to have launched an inquiry into the "alternate-source market" for prescription drugs, subpoenaing three large drug distributors for infomation on their purchases of drugs from other wholesalers instead of directly from drugmakers. Spitzer's office declined to disclose the focus of the inquiry. According to published reports, counterfeit drugs may be one area of concern. AmeriSourceBergen Corp., Chesterbrook, Pa., said Spitzer's office asked how and how often the company bought prescription drugs from other wholesalers; AmeriSourceBergen said less than 0.5% of the time. In a Securities and Exchange Commission filing, the company said it was told similar subpoenas had been issued to others in the industry. The company said it was not told of "any allegations of misconduct." Cardinal Health, Dublin, Ohio, and McKesson Corp., San Francisco, also confirmed receipt of a subpoena for information on the secondary wholesale market. -- by Mark Taylor
Drug distributors subpoenaed; counterfeits the target?
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.